RhumbLine Advisers’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,505
| Closed | -$5.51K | – | 4339 |
|
|
2024
Q2 | $5.51K | Sell |
5,505
-38,165
| -87% | -$38.2K | ﹤0.01% | 4072 |
|
|
2024
Q1 | $103K | Buy |
43,670
+680
| +2% | +$1.61K | ﹤0.01% | 3438 |
|
|
2023
Q4 | $96.7K | Sell |
42,990
-1,912
| -4% | -$4.3K | ﹤0.01% | 3459 |
|
|
2023
Q3 | $95.2K | Buy |
44,902
+2,292
| +5% | +$4.86K | ﹤0.01% | 3478 |
|
|
2023
Q2 | $132K | Buy |
+42,610
| New | +$132K | ﹤0.01% | 3422 |
|
|
2022
Q2 | – | Sell |
-16,332
| Closed | -$99K | – | 3245 |
|
|
2022
Q1 | $99K | Sell |
16,332
-2,000
| -11% | -$12.1K | ﹤0.01% | 2887 |
|
|
2021
Q4 | $213K | Buy |
18,332
+2,926
| +19% | +$34K | ﹤0.01% | 2818 |
|
|
2021
Q3 | $242K | Buy |
15,406
+3,869
| +34% | +$60.8K | ﹤0.01% | 2846 |
|
|
2021
Q2 | $215K | Buy |
11,537
+1,929
| +20% | +$35.9K | ﹤0.01% | 2907 |
|
|
2021
Q1 | $414K | Buy |
+9,608
| New | +$414K | ﹤0.01% | 2573 |
|